Puma Biotechnology Management
Management criteria checks 3/4
Puma Biotechnology's CEO is Alan Auerbach, appointed in Sep 2010, has a tenure of 13.58 years. total yearly compensation is $2.53M, comprised of 33.7% salary and 66.3% bonuses, including company stock and options. directly owns 14.2% of the company’s shares, worth $33.40M. The average tenure of the management team and the board of directors is 5.8 years and 7.4 years respectively.
Key information
Alan Auerbach
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 33.7% |
| CEO tenure | 13.6yrs |
| CEO ownership | 14.2% |
| Management average tenure | 5.8yrs |
| Board average tenure | 7.4yrs |
Recent management updates
Recent updates
Is There An Opportunity With Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 46% Undervaluation?
Apr 10
There's Reason For Concern Over Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Massive 31% Price Jump
Mar 01Here's Why Puma Biotechnology (NASDAQ:PBYI) Has A Meaningful Debt Burden
Dec 27Puma Biotechnology (NASDAQ:PBYI) Has A Somewhat Strained Balance Sheet
Sep 08Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%
Apr 17We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt
Dec 14Puma Biotechnology, Takeda enter licensing agreement for cancer treatment alisertib
Sep 20Puma Biotechnology (NASDAQ:PBYI) Takes On Some Risk With Its Use Of Debt
Sep 05Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M
Aug 04Is Puma Biotechnology (NASDAQ:PBYI) Using Debt Sensibly?
Jun 04Puma Bio: Still Worthy Of Consideration After Earnings Surprise
Mar 08Puma Bio: Recent Sell-Off Brings My Position Out Of Mothball
Aug 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$22m |
| Sep 30 2023 | n/a | n/a | US$4m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | US$5m |
| Dec 31 2022 | US$3m | US$852k | US$2k |
| Sep 30 2022 | n/a | n/a | US$10m |
| Jun 30 2022 | n/a | n/a | -US$34m |
| Mar 31 2022 | n/a | n/a | -US$49m |
| Dec 31 2021 | US$18m | US$827k | -US$29m |
| Sep 30 2021 | n/a | n/a | -US$48m |
| Jun 30 2021 | n/a | n/a | -US$35m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$4m | US$834k | -US$60m |
| Sep 30 2020 | n/a | n/a | -US$56m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$82m |
| Dec 31 2019 | US$4m | US$780k | -US$76m |
| Sep 30 2019 | n/a | n/a | -US$95m |
| Jun 30 2019 | n/a | n/a | -US$92m |
| Mar 31 2019 | n/a | n/a | -US$99m |
| Dec 31 2018 | US$6m | US$757k | -US$114m |
| Sep 30 2018 | n/a | n/a | -US$147m |
| Jun 30 2018 | n/a | n/a | -US$210m |
| Mar 31 2018 | n/a | n/a | -US$243m |
| Dec 31 2017 | US$3m | US$733k | -US$292m |
Compensation vs Market: Alan's total compensation ($USD2.53M) is above average for companies of similar size in the US market ($USD1.60M).
Compensation vs Earnings: Alan's compensation has been consistent with company performance over the past year.
CEO
Alan Auerbach (53 yo)
13.6yrs
Tenure
US$2,532,761
Compensation
Mr. Alan H. Auerbach is the Founder of Puma Biotechnology, Inc. and has been its Executive Chairman since October 4, 2011 and serves as its Chief Executive Officer, President and Secretary since September...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 13.6yrs | US$2.53m | 14.2% $ 33.4m | |
| CFO & Principal Accounting Officer | 5.4yrs | US$1.07m | 0.21% $ 484.9k | |
| Chief Scientific Officer | 2.8yrs | US$1.02m | 0.14% $ 334.9k | |
| Senior Vice President of Regulatory Affairs | 6.3yrs | US$738.38k | 0.16% $ 386.8k | |
| Chief Commercial Officer | 4.1yrs | US$1.10m | 0.14% $ 324.4k | |
| Senior Director of Investor Relations | 12.4yrs | no data | no data |
5.8yrs
Average Tenure
57yo
Average Age
Experienced Management: PBYI's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.5yrs | US$2.53m | 14.2% $ 33.4m | |
| Lead Independent Director | 12yrs | US$155.80k | 0.034% $ 79.7k | |
| Independent Director | 6.2yrs | US$148.30k | 0.034% $ 79.8k | |
| Independent Director | 10.5yrs | US$155.80k | 0.0019% $ 4.4k | |
| Director | 1.8yrs | US$237.43k | no data | |
| Independent Director | 8.7yrs | US$148.30k | no data | |
| Independent Director | 2.8yrs | US$138.30k | 0.035% $ 82.9k | |
| Independent Director | 3.8yrs | US$148.09k | 0.066% $ 155.9k |
7.4yrs
Average Tenure
60.5yo
Average Age
Experienced Board: PBYI's board of directors are considered experienced (7.4 years average tenure).